Literature DB >> 24486465

Magnetic micelles for DNA delivery to rat brains after mild traumatic brain injury.

Mahasweta Das1, Chunyan Wang2, Raminder Bedi3, Shyam S Mohapatra4, Subhra Mohapatra5.   

Abstract

Traumatic brain injury (TBI) causes significant mortality, long term disability and psychological symptoms. Gene therapy is a promising approach for treatment of different pathological conditions. Here we tested chitosan and polyethyleneimine (PEI)-coated magnetic micelles (CP-mag micelles or CPMMs), a potential MRI contrast agent, to deliver a reporter DNA to the brain after mild TBI (mTBI). CPMM-tomato plasmid (ptd) conjugate expressing a red-fluorescent protein (RFP) was administered intranasally immediately after mTBI or sham surgery in male SD rats. Evans blue extravasation following mTBI suggested CPMM-ptd entry into the brain via the compromised blood-brain barrier. Magnetofection increased the concentration of CPMMs in the brain. RFP expression was observed in the brain (cortex and hippocampus), lung and liver 48 h after mTBI. CPMM did not evoke any inflammatory response by themselves and were excreted from the body. These results indicate the possibility of using intranasally administered CPMM as a theranostic vehicle for mTBI. From the clinical editor: In this study, chitosan and PEI-coated magnetic micelles (CPMM) were demonstrated as potentially useful vehicles in traumatic brain injury in a rodent model. Magnetofection increased the concentration of CPMMs in the brain and, after intranasal delivery, CPMM did not evoke any inflammatory response and were excreted from the body.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bio-distribution; Brain; DNA delivery; LFPI; Magnetic micelle; TBI; Theranostic

Mesh:

Substances:

Year:  2014        PMID: 24486465      PMCID: PMC4338919          DOI: 10.1016/j.nano.2014.01.003

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  29 in total

1.  Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications.

Authors:  Brian Dalby; Sharon Cates; Adam Harris; Elise C Ohki; Mary L Tilkins; Paul J Price; Valentina C Ciccarone
Journal:  Methods       Date:  2004-06       Impact factor: 3.608

2.  The scope of early traumatic brain injury as a long-term health concern in two nationwide samples: prevalence and prognostic factors.

Authors:  Jonas G Halldorsson; Kjell M Flekkoy; Gudmundur B Arnkelsson; Kristinn Tomasson; Hulda Bra Magnadottir; Eirikur Orn Arnarson
Journal:  Brain Inj       Date:  2012       Impact factor: 2.311

3.  Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration.

Authors:  L C Schmued; C Albertson; W Slikker
Journal:  Brain Res       Date:  1997-03-14       Impact factor: 3.252

4.  MagnetofectionTM platform: from magnetic nanoparticles to novel nucleic acid therapeutics.

Authors:  Christian Plank; Dialechti Vlaskou; Ulrike Schillinger; Olga Mykhaylyk
Journal:  Ther Deliv       Date:  2011-06

5.  Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.

Authors:  Norased Nasongkla; Erik Bey; Jimin Ren; Hua Ai; Chalermchai Khemtong; Jagadeesh Setti Guthi; Shook-Fong Chin; A Dean Sherry; David A Boothman; Jinming Gao
Journal:  Nano Lett       Date:  2006-11       Impact factor: 11.189

6.  Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain.

Authors:  Michele Caraglia; Livio Luongo; Giuseppina Salzano; Silvia Zappavigna; Monica Marra; Francesca Guida; Sara Lusa; Catia Giordano; Vito De Novellis; Francesco Rossi; Alberto Abbruzzese Saccardi; Giuseppe De Rosa; Sabatino Maione
Journal:  Mol Pharm       Date:  2013-02-14       Impact factor: 4.939

7.  Ex vivo magnetofection with magnetic nanoparticles: a novel platform for nonviral tissue engineering.

Authors:  Shieh-Yueh Yang; Jui-Sheng Sun; Cheng-Heng Liu; Yang-Hwei Tsuang; Li-Ting Chen; Chin-Yih Hong; Hong-Chang Yang; Herng-Er Horng
Journal:  Artif Organs       Date:  2008-01-14       Impact factor: 3.094

8.  The significance of mild traumatic brain injury to cognition and self-reported symptoms in long-term recovery from injury.

Authors:  Mark L Ettenhofer; Norman Abeles
Journal:  J Clin Exp Neuropsychol       Date:  2008-07-11       Impact factor: 2.475

9.  Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles.

Authors:  Betzaida Castillo; Lev Bromberg; Xaira López; Valerie Badillo; Jose A González Feliciano; Carlos I González; T Alan Hatton; Gabriel Barletta
Journal:  J Drug Deliv       Date:  2012-08-30

Review 10.  New perspectives on central and peripheral immune responses to acute traumatic brain injury.

Authors:  Mahasweta Das; Subhra Mohapatra; Shyam S Mohapatra
Journal:  J Neuroinflammation       Date:  2012-10-12       Impact factor: 8.322

View more
  9 in total

Review 1.  Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Authors:  Howard E Gendelman; Vellareddy Anantharam; Tatiana Bronich; Shivani Ghaisas; Huajun Jin; Anumantha G Kanthasamy; Xinming Liu; JoEllyn McMillan; R Lee Mosley; Balaji Narasimhan; Surya K Mallapragada
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

Review 2.  Imaging of intranasal drug delivery to the brain.

Authors:  Michael C Veronesi; Mosa Alhamami; Shelby B Miedema; Yeonhee Yun; Miguel Ruiz-Cardozo; Michael W Vannier
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-02-25

Review 3.  Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics.

Authors:  Matthew L Pearn; Ingrid R Niesman; Junji Egawa; Atsushi Sawada; Angels Almenar-Queralt; Sameer B Shah; Josh L Duckworth; Brian P Head
Journal:  Cell Mol Neurobiol       Date:  2016-07-06       Impact factor: 5.046

Review 4.  Management of Traumatic Brain Injury: From Present to Future.

Authors:  Rosalia Crupi; Marika Cordaro; Salvatore Cuzzocrea; Daniela Impellizzeri
Journal:  Antioxidants (Basel)       Date:  2020-04-02

5.  Multi-Functional Drug Carrier Micelles With Anti-inflammatory Drug.

Authors:  Wei-Jie Wang; Yin-Chou Huang; Chao-Ming Su; Tzong-Rong Ger
Journal:  Front Chem       Date:  2019-02-25       Impact factor: 5.221

Review 6.  Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective.

Authors:  Manuela Curcio; Giuseppe Cirillo; Jourdin R C Rouaen; Federica Saletta; Fiore Pasquale Nicoletta; Orazio Vittorio; Francesca Iemma
Journal:  Pharmaceutics       Date:  2020-12-06       Impact factor: 6.321

Review 7.  Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review.

Authors:  Saffiya Habib; Moganavelli Singh
Journal:  Polymers (Basel)       Date:  2022-02-12       Impact factor: 4.329

8.  Gene Targeting to the Cerebral Cortex Following Intranasal Administration of Polyplexes.

Authors:  Asya I Petkova; Ilona Kubajewska; Alexandra Vaideanu; Andreas G Schätzlein; Ijeoma F Uchegbu
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

Review 9.  Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.

Authors:  J A Smith; T Leonardi; B Huang; N Iraci; B Vega; S Pluchino
Journal:  Biogerontology       Date:  2014-06-28       Impact factor: 4.277

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.